Sign In
Get Clay Free →

Suggestions

    Lori Englebert

    Senior Vice President, Commercial and Business Development at Axsome Therapeutics, Inc.

    Professional Background

    Lori Englebert is a seasoned leader in commercial and business development, with a wealth of experience that spans multiple sectors within the biopharmaceutical industry. Currently serving as the Senior Vice President of Commercial and Business Development at Axsome Therapeutics, Inc., Lori has been instrumental in advancing the company's goals through strategic initiatives and business growth programs. Her impressive trajectory at Axsome Therapeutics demonstrates both her expertise and dedication to driving success in a highly competitive environment. Prior to her current role, Lori held several significant positions at Axsome, including Vice President and Executive Director, where she significantly contributed to the commercial strategies that have propelled the company forward in the innovative field of neuroscience.

    Career Journey at Axsome Therapeutics

    Since joining Axsome Therapeutics, Lori has played a pivotal role in shaping the company's business development and commercial strategies. Her progressive advancement through various leadership roles from Executive Director to Senior Vice President illustrates not only her strategic acumen but also her capacity to lead teams effectively in delivering results. Under her guidance, Axsome has successfully navigated complex market dynamics, capitalizing on opportunities that have enhanced its competitive edge and fostered sustainable growth. Lori's vision and leadership have ensured that Axsome Therapeutics maintains its reputation as a leader in addressing numerous unmet medical needs in the psychiatric and neurological space.

    Contributions to Amgen

    Before her impactful journey at Axsome, Lori was a formidable force at Amgen, one of the world's leading biotechnology companies. Her tenure at Amgen spanned various strategic roles, including Executive Director for Global Marketing Lead, Hematology/Oncology, and Director of Neuroscience Commercial Strategic Planning. Lori's ability to innovate and execute commercial strategies that resonate with healthcare providers and patients has been a hallmark of her career at Amgen. In her positions there, she emphasized the importance of aligning brand strategies with patient needs, which resulted in successful product launches and market penetration in the hematology and oncology areas.

    Lori's role as Director, Global Brand Lead, Inflammation and Bone exemplifies her breadth of expertise across therapeutic areas, showcasing her versatility in managing complex commercial landscapes and coordinating cross-functional teams to achieve ambitious goals. In addition, she served as Director of Corporate Strategy & Business Development, where she played a critical role in identifying and facilitating key strategic partnerships and collaborations that have fortified Amgen's position in the biotechnology market.

    Earlier Career Development

    Lori's professional background extends further into her earlier career experiences which laid the groundwork for her tremendous success. With a strong foundation in operations and strategy, her roles have included positions such as Senior Manager, International Commercial Business Strategy at Amgen and Portfolio Manager in Commercial Real Estate at First Tennessee Bank. Each of these roles allowed her to cultivate her analytical skills, deepen her understanding of market dynamics, and develop strategic frameworks that would serve her well in her subsequent leadership positions.

    Additionally, Lori gained valuable experience in global business planning and analytics at Novartis, which equipped her with analytical skills required to support high-level decision-making processes. She commenced her career in financial services at Bloomberg LP, where she honed her capabilities in business development and strategic sales, establishing a robust skill set that would become intrinsic to her roles in the biotechnology sector.

    Education and Achievements

    Lori Englebert holds an MBA from Wake Forest University School of Business, where she honed her business acumen and developed a strategic mindset tailored for the ever-evolving landscapes of healthcare and biopharmaceutical marketing. Her educational background was complemented by a Bachelor of Arts degree from Wake Forest University, establishing a strong academic foundation that has been vital throughout her career.

    Throughout her career, Lori has been recognized for her contributions within the commercial sector. Her ability to cultivate collaborative relationships, foster innovation, and implement effective strategies has established her as a respected leader in the industry. Lori’s insight into market trends and customer needs has been pivotal in driving initiatives that prioritize patient access to life-changing therapies.

    Notable Achievements

    • Instrumental in the successful launch of multiple innovative therapies at both Axsome Therapeutics and Amgen, focusing on addressing critical health issues in hematology, oncology, and neuroscience.
    • Recognized for her leadership at Amgen, particularly in driving commercial strategies that led to a significant increase in market share for key therapeutic areas.
    • Played a key role in forging strategic partnerships and collaborations that enhanced Amgen's portfolio and accelerated drug development processes.
    • Developed and led high-performing teams to achieve commercial goals, demonstrating her ability to inspire and motivate others.
    • Engaged in strategic planning and business development initiatives that resulted in robust operational frameworks within both organizations.
    • Continuously contributed to the professional development of her teams, emphasizing mentorship and guidance to nurture emerging leaders in the healthcare field.

    Conclusion

    Lori Englebert's exceptional background in commercial and business development within the pharmaceutical industry showcases her as a dynamic and accomplished professional. Her roles at Axsome Therapeutics, Amgen, and beyond reflect her strategic vision, leadership capabilities, and a deep commitment to advancing healthcare through innovative solutions. As she continues her journey, Lori's expertise will undoubtedly play a significant role in shaping the future of biopharmaceutical development and commercialization.

    Education and Achievements

    Lori Englebert holds an MBA from Wake Forest University School of Business, as well as a Bachelor of Arts from Wake Forest University.

    Related Questions

    How did Lori Englebert develop her expertise in commercial and business development within the pharmaceutical industry?
    What strategies has Lori Englebert implemented at Axsome Therapeutics to drive commercial success?
    How has Lori Englebert's educational background contributed to her professional achievements?
    What impact did Lori Englebert have during her tenure at Amgen, particularly in the oncology and hematology divisions?
    How has Lori Englebert’s leadership style influenced her teams at Axsome Therapeutics?
    Lori Englebert
    Add to my network

    Location

    New York, New York, United States